title: Gain in recombinant human erythropoietin dosage with continuous intravenous intradialytic administration for the treatment of anaemia in end-stage renal disease.
authors.forename: M
authors.initials: M
authors.lastname: Liani
authors.forename: F
authors.initials: F
authors.lastname: Salvati
authors.forename: M
authors.initials: M
authors.lastname: Golato
authors.forename: R
authors.initials: R
authors.lastname: Cahen
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D006435:Renal Dialysis
chemical_list: D004921:Erythropoietin